Logo

Sigma and Ingex to Develop Prokaryotic Gene-Disruption System

Oct 14, 2004

NEW YORK, Oct. 14 (GenomeWeb News) - Germany-based Sigma-Aldrich and St. Louis, Mo.-based Ingex will collaborate in the development of a "novel" targeted prokaryotic gene-disruption technology, Sigma said yesterday in a statement.

 

The companies' TargeTron technology involves targeted insertion of a "TargeTron group II" intron into a host genome, resulting in "permanent" target gene knockout into a variety of prokaryotic genomes, said the statement. Targeted insertion is "more than 90 percent successful" and will work "across a broad range" of prokaryotes, the company added.

 

Future systems are planned for targeted plant and mammalian gene disruption, Sigma said.

 

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.